436
Views
17
CrossRef citations to date
0
Altmetric
Review

Exendins and exendin analogs for diabetic therapy: a patent review (2012-2015)

, , &
Pages 833-842 | Received 03 Mar 2016, Accepted 17 May 2016, Published online: 09 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Eun Ji Park, Jiyoung Choi, Kang Choon Lee & Dong Hee Na. (2019) Emerging PEGylated non-biologic drugs. Expert Opinion on Emerging Drugs 24:2, pages 107-119.
Read now

Articles from other publishers (16)

Javiera Miranda, Nicolás Lefin, Jorge F. Beltran, Lisandra Herrera Belén, Argyro Tsipa, Jorge G. Farias & Mauricio Zamorano. (2023) Enzyme Engineering Strategies for the Bioenhancement of l-Asparaginase Used as a Biopharmaceutical. BioDrugs 37:6, pages 793-811.
Crossref
Ziqi Zhang, Qiling Zhang, Ying Tan, Yu Chen, Xiqiao Zhou, Su Liu & Jiangyi Yu. (2023) GLP-1RAs caused gastrointestinal adverse reactions of drug withdrawal: a system review and network meta-analysis. Frontiers in Endocrinology 14.
Crossref
Han Liu, Baorui Wang, Mengzhen Xing, Fanda Meng, Suohui Zhang, Guozhong Yang, Aguo Cheng, Chenxin Yan, Bo Xu & Yunhua Gao. (2023) Thermal stability of exenatide encapsulated in stratified dissolving microneedles during storage. International Journal of Pharmaceutics 636, pages 122863.
Crossref
Jae Cheon Kim, Eun Ji Park & Dong Hee Na. (2022) Gastrointestinal Permeation Enhancers for the Development of Oral Peptide Pharmaceuticals. Pharmaceuticals 15:12, pages 1585.
Crossref
Lin Wang, Yin Cai, Liguo Jian, Chi Wai Cheung, Liangqing Zhang & Zhengyuan Xia. (2021) Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy. Cardiovascular Diabetology 20:1.
Crossref
Reeju Amatya, Taehoon Park, Seungmi Hwang, JaeWook Yang, Yoonjin Lee, Heesun Cheong, Cheol Moon, Hyun Duck Kwak, Kyoung Ah Min & Meong Cheol Shin. (2020) Drug Delivery Strategies for Enhancing the Therapeutic Efficacy of Toxin-Derived Anti-Diabetic Peptides. Toxins 12:5, pages 313.
Crossref
Lotte Bjerre Knudsen & Jesper Lau. (2019) The Discovery and Development of Liraglutide and Semaglutide. Frontiers in Endocrinology 10.
Crossref
Yina Song, Yanan Shi, Liping Zhang, Haiyan Hu, Chunyan Zhang, Miaomiao Yin, Liuxiang Chu, Xiuju Yan, Mingyu Zhao, Xuemei Zhang, Hongjie Mu & Kaoxiang Sun. (2019) Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption. Molecular Pharmaceutics 16:2, pages 518-532.
Crossref
Sohee Son, Eun Ji Park, Yejin Kim, Kang Choon Lee & Dong Hee Na. (2018) Chemical chaperone-conjugated exendin-4 as a cytoprotective agent for pancreatic β-cells. The International Journal of Biochemistry & Cell Biology 105, pages 13-19.
Crossref
Fakhrossadat Emami, Alireza Vatanara, Eun Park & Dong Na. (2018) Drying Technologies for the Stability and Bioavailability of Biopharmaceuticals. Pharmaceutics 10:3, pages 131.
Crossref
Lujin Wu, Ke Wang, Wei Wang, Zheng Wen, Peihua Wang, Lei Liu & Dao Wen Wang. (2018) Glucagon-like peptide-1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPARα pathway. Aging Cell 17:4, pages e12763.
Crossref
Jia Ying Cheang & Peter M. Moyle. (2018) Glucagon‐Like Peptide‐1 (GLP‐1)‐Based Therapeutics: Current Status and Future Opportunities beyond Type 2 Diabetes. ChemMedChem 13:7, pages 662-671.
Crossref
Dawood Khan, Charlotte R. Moffet, Peter R. Flatt & Catriona Kelly. (2018) Role of islet peptides in beta cell regulation and type 2 diabetes therapy. Peptides 100, pages 212-218.
Crossref
H. ChilukuriM. J. Kulkarni & M. Fernandes. (2018) Revisiting amino acids and peptides as anti-glycation agents. MedChemComm 9:4, pages 614-624.
Crossref
Uli Binder & Arne Skerra. (2017) PASylation®: A versatile technology to extend drug delivery. Current Opinion in Colloid & Interface Science 31, pages 10-17.
Crossref
Kang Choon Lee & Seulki Lee. (2017) Drug delivery: Brushing off antigenicity. Nature Biomedical Engineering 1:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.